Drug Therapies – Allowed
Back to Administration Guidelines
2024 Allowed Medications
Single NSAIDS do not require a Medication Report if used as per the guidelines. Isoxsuprine, Pentoxifyline and Prascend require a single Medication Report by the start of the show validating diagnosis and prescription. All others require a Medication Report filed within 24 hours of administration, or whenever NOT used per this guideline.
Version 5.1 -ESC Board Approved Effective June 1, 2024
Version 5.1 - Approved, Controlled and Banned Substances modified in presence of ESC PAC.
Click the "+" (Drug Name column) to view additional advisory Notes.
To Search enter the drug name or category such as corticosteroids